The SENS (Strategies for Engineered Negligible Senescence) Organization is a company that deals with anti-aging research. According to recent reports, the organization is focusing more on age breakers. Age breakers are also defined as treatments that focus on glycation end products that form on the skin and muscle tissue. It is these products that are responsible for degrading blood vessels and the skin. Scientists have realized that glucosepane is the major end product affecting humans hence they are focusing efforts on breaking down glucosepane from tissues. The expected end results would be sustaining the muscle and skin tissue more hence retaining the youthfulness of an individual.Jason Hope is one of the major donors in the course towards anti-aging research, among other wealthy donors like Peter Thiel, the co-founder of PayPal.
Thiel donated at least $3.5 million in 2006 only, which aided the company pilot its research projects. Google co-founders Larry Page and Sergey Brin are also investing into similar rejuvenation biotechnologies such as the Calico Company where they invested $100 million. Calico is headed by Apple chairperson, also former Genentech CEO, Art Levinson.Thiel and Jason are some of the major entrepreneurs that are seeking to invest in the future of humanity. In his website, Jason pointed out that he has a personal passion for helping out the humanity, including offering business advice to companies that are contributing to social and scientific causes. He is of the opinion that while most medical research centers require good funding, it is the brains behind the organization that help SENS Foundation to stand out.
Dr. Aubrey de Grey is a British biogerontologist who works as the chief science officer in the foundation. He has since become the voice of reason in the anti-aging industry, and he is popular for his controversial TED Talk where he mentioned that the first humans to be 1,000 years old are currently living today.In current topics, rejuvenation biotechnologies are seemingly taking the current paradigm in the healthcare industry with many companies thinking of eliminating aging as a great risk to losing the market for pharmaceutical drugs that produce products for the ailing, aging populace. The old are mostly affected by diseases hence the largest market for pharmaceutical companies. However, the truth still remains that ending aging does mean cheating death. As such, the breakthroughs brought about by rejuvenation medicine are not necessarily opposing the current trends on diseases.
— Jason Hope (@JasonHope) March 7, 2016